1129-53-9 Usage
General Description
3,4-Dihydroxyphenylacetamide, also known as 4-hydroxy-3-(hydroxymethyl)phenylacetamide, is a chemical compound with the molecular formula C8H9NO4. 3,4-DIHYDROXYPHENYLACETAMIDE is a derivative of acetamide and contains two hydroxyl groups attached to a benzene ring. It is commonly used in the synthesis of pharmaceuticals, particularly in the development of drugs targeting neurodegenerative disorders. 3,4-Dihydroxyphenylacetamide has also been studied for its potential antioxidant properties and its ability to protect cells from oxidative stress. Additionally, it has been investigated for its potential role in the treatment of Parkinson's disease. Overall, this compound exhibits promising pharmacological properties and is the subject of ongoing research in the fields of medicine and drug development.
Check Digit Verification of cas no
The CAS Registry Mumber 1129-53-9 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,1,2 and 9 respectively; the second part has 2 digits, 5 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1129-53:
(6*1)+(5*1)+(4*2)+(3*9)+(2*5)+(1*3)=59
59 % 10 = 9
So 1129-53-9 is a valid CAS Registry Number.
InChI:InChI=1/C8H9NO3/c9-8(12)4-5-1-2-6(10)7(11)3-5/h1-3,10-11H,4H2,(H2,9,12)
1129-53-9Relevant articles and documents
Synthesis, characterization and cardioprotective activity of some novel benzotriazole and pyrazole derivatives
Gudaparthi, Vijayalakshmi,Bharathi,Panda, Jagadeesh
experimental part, p. 5323 - 5330 (2012/07/28)
A series of N-(1-(1H-benzo[d]) [1,2,3]triazol-1-yl)-2,2-dimethyl propyl)-2-(substituted phenyl) acetamide derivatives and methyl 5-((4- (2,5-disubstituted phenyl) furan-2 carboxylate derivatives are prepared from different substituted aryl carboxylic acids, phenyl acetic acid and cinnamic acid, respectively. All the synthesized compounds are investigated for cardioprotective activity by ischemia reperfusion method, while all the compounds show significant activity.
Hydroxybenzohydroxamic acids, benzamides and esters and related compounds as ribonucleotide reductase inhibitors
-
, (2008/06/13)
Di, tri and tetrahydroxybenzohydroxamic acids, amides and the corresponding di, tri and tetrahydroxy substituted phenylalkanohydroxamic acids, amides and phenyl esters, ribonucleotide reductase inhibitors.
